SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Amit Goel, Mahesh Gupta, Rakesh Aggarwal, Gut microbiota and liver disease, Journal of Gastroenterology and Hepatology, 2014, 29, 6
  2. 2
    Ying-Ying Yang, Shie-Liang Hsieh, Pei-Chang Lee, Yi-Chen Yeh, Kuei-Chuan Lee, Yun-Cheng Hsieh, Ying-Wen Wang, Tzung-Yan Lee, Yi-Hsiang Huang, Che-Chang Chan, Han-Chieh Lin, Long-term cannabinoid type 2 receptor agonist therapy decreases bacterial translocation in rats with cirrhosis and ascites, Journal of Hepatology, 2014, 61, 5, 1004

    CrossRef

  3. 3
    Prasant Kumar, Ayush V. Ranawade, Naresh G. Kumar, Potential ProbioticEscherichia coli16 Harboring theVitreoscillaHemoglobin Gene Improves Gastrointestinal Tract Colonization and Ameliorates Carbon Tetrachloride Induced Hepatotoxicity in Rats, BioMed Research International, 2014, 2014, 1

    CrossRef

  4. 4
    Kirsten E. Pijls, Daisy M. A. E. Jonkers, Elhaseen E. Elamin, Ad A. M. Masclee, Ger H. Koek, Intestinal epithelial barrier function in liver cirrhosis: an extensive review of the literature, Liver International, 2013, 33, 10
  5. 5
    Pamela Christudoss, Ratnasamy Selvakumar, Anna Benjamin Pulimood, Jude Joseph Fleming, George Mathew, Protective Role of Aspirin, Vitamin C, and Zinc and their Effects on Zinc Status in the DMH-Induced Colon Carcinoma Model, Asian Pacific Journal of Cancer Prevention, 2013, 14, 8, 4627

    CrossRef

  6. 6
    Giuseppe D'Argenio, Rita Cariello, Concetta Tuccillo, Giovanna Mazzone, Alessandro Federico, Annalisa Funaro, Laura Magistris, Enzo Grossi, Maria L. Callegari, Marilena Chirico, Nicola Caporaso, Marco Romano, Lorenzo Morelli, Carmela Loguercio, Symbiotic formulation in experimentally induced liver fibrosis in rats: intestinal microbiota as a key point to treat liver damage?, Liver International, 2013, 33, 5
  7. 7
    Stelios F. Assimakopoulos, Athanassios C. Tsamandas, Georgios I. Tsiaoussis, Elli Karatza, Christos Triantos, Constantine E. Vagianos, Iris Spiliopoulou, Valeria Kaltezioti, Aristidis Charonis, Vassiliki N. Nikolopoulou, Chrisoula D. Scopa, Konstantinos C. Thomopoulos, Altered intestinal tight junctions’ expression in patients with liver cirrhosis: a pathogenetic mechanism of intestinal hyperpermeability, European Journal of Clinical Investigation, 2012, 42, 4
  8. 8
    Zora Teltschik, Reiner Wiest, Julia Beisner, Sabine Nuding, Claudia Hofmann, Juergen Schoelmerich, Charles L. Bevins, Eduard F. Stange, Jan Wehkamp, Intestinal bacterial translocation in rats with cirrhosis is related to compromised paneth cell antimicrobial host defense, Hepatology, 2012, 55, 4
  9. 9
    Sathish Kumar Natarajan, Weidong Zhu, Xinwen Liang, Lu Zhang, Andrew J. Demers, Matthew C. Zimmerman, Melanie A. Simpson, Donald F. Becker, Proline dehydrogenase is essential for proline protection against hydrogen peroxide-induced cell death, Free Radical Biology and Medicine, 2012, 53, 5, 1181

    CrossRef

  10. 10
    Stelios F. Assimakopoulos, Charalambos Gogos, Chrisoula Labropoulou-Karatza, Could antioxidants be the “magic pill” for cirrhosis-related complications? A pathophysiological appraisal, Medical Hypotheses, 2011, 77, 3, 419

    CrossRef

  11. 11
    Chinatsu Iida, Kozue Fujii, Eriko Koga, Yukiko Washino, Yuko Kitamura, Ikuyo Ichi, Kouichi Abe, Tatsuya Matsura, Shosuke Kojo, Effect of α-tocopherol on carbon tetrachloride intoxication in the rat liver, Archives of Toxicology, 2009, 83, 5, 477

    CrossRef

  12. 12
    Sathish Kumar Natarajan, G Jayakumar Amirtharaj, Anup Ramachandran, Anna B Pulimood, Kunissery A Balasubramanian, Retinoid metabolism in the small intestine during development of liver cirrhosis, Journal of Gastroenterology and Hepatology, 2009, 24, 5
  13. 13
    Andres T Blei, Portal hypertension and its complications, Current Opinion in Gastroenterology, 2007, 23, 3, 275

    CrossRef